CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
8.17
+0.50 (6.52%)
At close: Aug 18, 2026, 4:00 PM EDT
8.21
+0.04 (0.49%)
Pre-market: Aug 19, 2026, 7:09 AM EDT

CorMedix Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, CorMedix stock has a consensus rating of "Buy" and an average price target of $15.4. The average 1-year stock price forecast is 88.49% higher than the current stock price, while the lowest is $13 (+59.12%) and the highest is $19 (+132.56%).

Price Target: $15.4 (+88.49%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$13$15.4$15$19
Change+59.12%+88.49%+83.60%+132.56%

Analyst Ratings

The average analyst rating for CorMedix stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy443222
Buy333333
Hold000000
Sell000000
Strong Sell000000
Total776555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Buy
Maintains
$13$14
BuyMaintains$13$14+71.36%Aug 14, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$13
BuyReiterates$13+59.12%Aug 14, 2026
Needham
Needham
Buy
Maintains
$15
BuyMaintains$15+83.60%Aug 13, 2026
Leerink Partners
Leerink Partners
Buy
Reiterates
$14$15
BuyReiterates$14$15+83.60%May 15, 2026
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
337.09M
from 311.71M
Increased by 8.14%
Revenue Next Year
286.45M
from 337.09M
Decreased by -15.02%
EPS This Year
0.97
from 2.15
Decreased by -54.80%
EPS Next Year
0.35
from 0.97
Decreased by -63.92%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
190.94K65.41K-43.47M311.71M337.09M
Revenue Growth
-20.19%-65.74%--617.03%8.14%
Operating Income
-29.44M-30.62M-48.96M-22.36M160.34M78.51M
Net Income
-28.21M-29.70M-46.34M-17.93M163.06M45.16M
EPS
----2.150.97
EPS Growth
------54.80%
Forward PE
---12.274.158.42
Free Cash Flow
-12.73M-14.03M-22.97M-44.72M108.51M92.86M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High344.0M
Avg337.1M
Low335.0M

Revenue Growth

Revenue Growth202620272028
High
10.4%
Avg
8.1%
Low
7.5%

EPS Forecast

EPS202620272028
High0.97
Avg0.97
Low0.97

EPS Growth

EPS Growth202620272028
High
-54.8%
Avg
-54.8%
Low
-54.8%